ACAD
33.79
-0.92
-2.65%
AEMD
2.193
+0.073
+3.4198%
APRI
1.17
+0.01
+0.8534%
ARNA
1.4
+0.01
+0.72%
ATEC
2.01
+0.03
+1.52%
CNAT
8.36
+0.84
+11.17%
CRXM
0.2
0.00
0.00%
CYTX
1.06
0.00
0.00%
DXCM
75.86
+0.92
+1.23%
GNMK
13.06
+0.21
+1.59%
HALO
13.99
+0.03
+0.21%
ILMN
182.97
+1.47
+0.81%
INNV
0.094
+0.001
+0.967%
INO
6.69
-0.1
-1.47%
ISCO
1.75
+0.12
+7.36%
ISIS
57.56
0.00
0.00%
LGND
109.505
+0.605
+0.556%
LPTN
2.93
0.00
0.00%
MBVX
2.07
-0.01
-0.4663%
MEIP
1.54
-0.02
-1.2692%
MNOV
5.92
+0.35
+6.28%
MRTX
4.65
+0.05
+1.09%
MSTX
0.138
+0.002
+1.6260%
NBIX
53.58
-0.04
-0.07%
NUVA
73.56
-3.38
-4.39%
ONCS
1.18
+0.02
+1.72%
ONVO
2.849
+0.069
+2.4928%
OREX
3.19
+0.09
+2.90%
OTIC
13.65
+0.45
+3.41%
QDEL
24.13
-0.37
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
1.475
+0.025
+1.724%
RMD
71.79
+0.85
+1.20%
SPHS
2.588
-0.012
-0.4500%
SRNE
1.975
+0.075
+3.947%
TROV
0.914
+0.037
+4.231%
VICL
2.332
-0.028
-1.1991%
VOLC
18
0.00
0.00%
ZGNX
10.9
+0.1
+0.93%
ACAD
33.79
-0.92
-2.65%
AEMD
2.193
+0.073
+3.4198%
APRI
1.17
+0.01
+0.8534%
ARNA
1.4
+0.01
+0.72%
ATEC
2.01
+0.03
+1.52%
CNAT
8.36
+0.84
+11.17%
CRXM
0.2
0.00
0.00%
CYTX
1.06
0.00
0.00%
DXCM
75.86
+0.92
+1.23%
GNMK
13.06
+0.21
+1.59%
HALO
13.99
+0.03
+0.21%
ILMN
182.97
+1.47
+0.81%
INNV
0.094
+0.001
+0.967%
INO
6.69
-0.1
-1.47%
ISCO
1.75
+0.12
+7.36%
ISIS
57.56
0.00
0.00%
LGND
109.505
+0.605
+0.556%
LPTN
2.93
0.00
0.00%
MBVX
2.07
-0.01
-0.4663%
MEIP
1.54
-0.02
-1.2692%
MNOV
5.92
+0.35
+6.28%
MRTX
4.65
+0.05
+1.09%
MSTX
0.138
+0.002
+1.6260%
NBIX
53.58
-0.04
-0.07%
NUVA
73.56
-3.38
-4.39%
ONCS
1.18
+0.02
+1.72%
ONVO
2.849
+0.069
+2.4928%
OREX
3.19
+0.09
+2.90%
OTIC
13.65
+0.45
+3.41%
QDEL
24.13
-0.37
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
1.475
+0.025
+1.724%
RMD
71.79
+0.85
+1.20%
SPHS
2.588
-0.012
-0.4500%
SRNE
1.975
+0.075
+3.947%
TROV
0.914
+0.037
+4.231%
VICL
2.332
-0.028
-1.1991%
VOLC
18
0.00
0.00%
ZGNX
10.9
+0.1
+0.93%
Home » Archive by Category

Xconomy

Angionetics Nears Key Gene Therapy Trial for Coronary Heart Disease

April 3, 2017 – 8:40 pm

Christopher Reinhard will tell you there is nothing unusual about the 20-plus years he’s spent getting an experimental heart therapy to late-stage clinical trials. “Very rarely will you get a short…

[[Click headline to continue reading.]]

How Battling New Epidemics Helps Fight Age-Old Killers

April 3, 2017 – 1:20 am

Washington state has reported nearly 300 cases of mumps this winter and experts predict this may be the state’s worst flu season in years, a stark reminder of how dangerous even familiar viruses can…

[[Click headline to continue reading.]]

Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More

March 31, 2017 – 2:45 am

As far as singular weeks go for biotech, this was a big one. Three highly anticipated drugs were approved. One is the first injectable medication for eczema. Another might help fend off the…

[[Click headline to continue reading.]]

Echo Raises $7.5M to Meet Big Orders for Hybrid Digital Microscope

March 30, 2017 – 12:56 pm

Echo, a San Diego startup that has developed a digital, all-in-one microscope, says today it has closed on $7.5 million in a Series A round led by San Francisco-based Dolby Family Ventures and…

[[Click headline to continue reading.]]

Mary Lou Jepsen, Moonshots, and the Human Impact of Innovation

March 29, 2017 – 7:19 am

As expressions go, “moonshot” has recently been gaining a lot of popularity in the media vernacular. Many folks assume that it arose with NASA’s Apollo 11 mission to the moon. But it’s a matter of…

[[Click headline to continue reading.]]

ViaCyte Working with Gore to Improve its Synthetic Pancreas Device

March 29, 2017 – 5:00 am

San Diego-based ViaCyte said today it is collaborating with W.L. Gore & Associates, the privately held company that makes Gore-Tex fabrics, medical devices, and other products, in a bid to…

[[Click headline to continue reading.]]

Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO

March 27, 2017 – 7:35 am

Akcea Therapeutics, an Ionis Pharmaceuticals subsidiary focused on rare lipid disorders, is spinning out of its parent with plans for an initial public stock offering as it prepares to file for FDA…

[[Click headline to continue reading.]]

Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC

March 24, 2017 – 3:25 am

Who knew healthcare could be so complicated? This week, President Trump and the GOP saw first hand, as a feverish rally to get their healthcare bill through the House of Representatives on Thursday…

[[Click headline to continue reading.]]

Today Only: Save $70 for Human Impact of Innovation on April 19th

March 23, 2017 – 2:45 am

Xconomy is convening life sciences and technology founders, executives, investors, and entrepreneurs for an afternoon of fireside chats and solo talks at Human Impact of Innovation. A few topics…

[[Click headline to continue reading.]]

Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio

March 23, 2017 – 2:30 am

It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference. There has been…

[[Click headline to continue reading.]]